Multisite virological influenza surveillance in India: 2004-2008. 2012

Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
National Institute of Virology, Pune, India All India Institute of Medical Sciences, New Delhi, India.

BACKGROUND Influenza surveillance is important to identify circulating, emerging/reemerging strains and unusual epidemiological trends. With these objectives, a multisite human influenza surveillance network was initiated in India in 2004. METHODS Epidemiologic data and throat swabs for laboratory testing were collected from patients with influenza-like illness (ILI) and severe acute respiratory infections (SARI). Virus isolation was carried out in Madin-Darby canine kidney cells and strains identified by hemagglutination inhibition assay. Meteorological data were collected. RESULTS From September 2004 to December 2008, 617 (4·43%) of 13928 cases yielded isolates: 27·8% were influenza A(H1N1), 29·8% were type A(H3N2), and 42·3% were type B. The yearly type and subtype distribution varied significantly from site to site. Peak influenza activity was observed from June to August in Delhi, Pune, and Kolkata and October to December in Chennai. Maximum influenza activity was seen during the rains in Delhi, Pune, Chennai, and Kolkata in correlation with virus isolations. Multivariate analysis of ILI cases showed chill/rigors, cough, fatigue, and ILI in family, correlated positively with isolation. Genetic analysis of Indian isolates revealed that viruses matched with vaccine strains by and large. Overlapping between circulating and vaccine component strains of consecutive years was also observed. CONCLUSIONS Seasonal influenza A(H1N1), H3N2, and type B co-circulated in all regions without any particular pattern of movement of any subtype. Year-round limited influenza activity with peaks during rains was observed. Genetic drifts and varying seasonality in different parts of the country suggest that a staggered timing of vaccination may be appropriate for India.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D009981 Influenza B virus Species of the genus BETAINFLUENZAVIRUS that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed. Betainfluenzavirus influenzae,FLUBV,Human Influenza B Virus,Influenza Viruses Type B,Influenza virus type B,Orthomyxoviruses Type B,Influenza B viruses
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D005260 Female Females

Related Publications

Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
February 2009, Zhongguo yi miao he mian yi,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
July 2011, Microbiology and immunology,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
December 2012, The Journal of infectious diseases,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
June 2009, Emerging infectious diseases,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
December 2011, Revista panamericana de salud publica = Pan American journal of public health,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
January 2022, PLOS global public health,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
January 1992, Communicable disease report. CDR weekly,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
January 2005, Communicable diseases intelligence quarterly report,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
January 2009, Przeglad epidemiologiczny,
Mandeep S Chadha, and Shobha Broor, and Palani Gunasekaran, and Varsha A Potdar, and Anand Krishnan, and Mamta Chawla-Sarkar, and Dipankar Biswas, and Asha M Abraham, and Suresh V Jalgaonkar, and Harpreet Kaur, and Alexander Klimov, and Renu B Lal, and Ann Moen, and Lalit Kant, and Akhilesh C Mishra
December 2012, The Journal of infectious diseases,
Copied contents to your clipboard!